Phase II clinical trials in oncology: Strengths and limitations of two-stage designs

James Schlesselman, Isildinha Reis

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II clinical trials in oncology: Strengths and limitations of two-stage designs'. Together they form a unique fingerprint.

Medicine & Life Sciences